KACTUS, a biotechnology research reagent provider based in Waltham, Massachusetts, announced the commercial availability of ultra-low endotoxin recombinant human kallikrein-1 proteins designed to ...
New research from Washington University School of Medicine in St. Louis adds to growing evidence that helping brain cells ...